NeurologyLive® Friday 5 — December 10, 2021

Welcome to NeurologyLive^®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive^®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Overview of Telehealth in Clinical Practice and Patient Options in SMA

In episode 3 of this NeurologyLive^® roundtable discussion, "Lessons Learned in Telehealth When Implementing Multidisciplinary Care for Patients Affected by SMA," Claudia Chiraboga, MD, and Cara Yochai, PT, discuss how they have used telehealth in their clinical practice and what services patients have at their disposal.

2: Acute and Preventative Migraine Treatment: Advice for Neurologists

David Kudrow, MD, shares some advice for community neurologists on the acute and preventive treatment of migraine in episode 7 of the NeurologyLive^® Insights series, "Expert Perspectives on the Management of Acute and Preventative Migraine."

3: NeuroVoices: Jessica Fesler, MD, on the Need to Improve and Integrate Seizure Tracking Apps

The staff epileptologist at Cleveland Clinic’s Epilepsy Center discussed the current state of seizure tracking applications, their limitations, and their untapped potential to be integrated in clinical care and with electronic medical records.

4: S1P Receptor Modulators for RRMS

In episode 6 of the NeurologyLive^® Peer Exchange series, "Oral Therapy Options for Relapsing-Remitting Multiple Sclerosis," experts Jennifer Graves, MD, PhD, MAS; Gabrielle Macaron, MD; and Suma Shah, MD, discuss what to know about using S1P receptor modulators as oral therapy for relapsing-remitting multiple sclerosis.

5: COVID-19 Vaccination in Patients with Dravet Syndrome: Veronica Hood, PhD, MS

The scientific director at the Dravet Syndrome Foundation discussed a recent survey asking caregivers about the experiences of patients with Dravet syndrome following COVID-19 vaccination after her presentation on the topic at the American Epilepsy Society's annual meeting.

—————————————————

Introducing: Giants of Multiple Sclerosis™

Recognize and celebrate the individuals who have achieved landmark successes within multiple sclerosis! Giants of Multiple Sclerosis™ is a premier neuroscience award that celebrates pioneers, innovators, and future generations of leaders who have been selected by their peers for their remarkable achievements in Multiple Sclerosis.

Nominate Someone Today for a 2022 Giants of Multiple Sclerosis™ Award

• Nominations are open through January 31, 2022
• The Giants of Multiple Sclerosis™ Steering Committee will vet all nominations and vote to determine the 2022 inductees
• Nominees will be selected on the merits of their lifetime work.
• One honoree in each category who makes a measurable difference in the lives of patients will be awarded.
• The 2022 Giants of Multiple Sclerosis™ inaugural class will be announced in Spring of 2022

Nominate someone here.